|
|
Volumn 13, Issue 1, 2002, Pages 10-11
|
|
Modulation of 5-fluorouracil/leucovorin by trimetrexate - Did it work?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DIHYDROPYRIMIDINE DEHYDROGENASE;
DOXORUBICIN;
FLUOROURACIL;
FOLINIC ACID;
IRINOTECAN;
LOPERAMIDE;
METHOTREXATE;
OXALIPLATIN;
PLACEBO;
RALTITREXED;
THYMIDYLATE SYNTHASE;
TRIMETREXATE;
ADVANCED CANCER;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG POTENTIATION;
EDITORIAL;
HEMATOLOGIC DISEASE;
HUMAN;
OUTCOMES RESEARCH;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
STATISTICAL ANALYSIS;
SURVIVAL TIME;
ANTIMETABOLITES, ANTINEOPLASTIC;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
DRUG SYNERGISM;
FLUOROURACIL;
HUMANS;
LEUCOVORIN;
PLACEBOS;
RANDOMIZED CONTROLLED TRIALS;
SURVIVAL RATE;
TREATMENT OUTCOME;
TRIMETREXATE;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0036224841
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1093/annonc/mdf086 Document Type: Editorial |
|
Times cited : (2)
|
|
References (11)
|
